Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Finch Therapeutics Group Inc
(NQ:
FNCH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Finch Therapeutics Group Inc
< Previous
1
2
3
Next >
Acurx Pharmaceuticals CEO Is Confident His Ibezapolstat Can Earn Front-Line Designation To Treat C. difficile…Here’s Why ($ACXP)
February 08, 2023
Via
AB Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 25, 2023
Via
Benzinga
Finch Therapeutics Halts Work On Its Only Clinical Stage Asset, Cuts 95% Of Workforce
January 24, 2023
Via
Benzinga
Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other Assets
January 24, 2023
From
Finch Therapeutics Group, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Via
Benzinga
Finch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Finch Therapeutics Group, Inc.
Via
GlobeNewswire
Finch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx Conference
November 09, 2022
From
Finch Therapeutics Group, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.
Via
Benzinga
Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile Infection
October 24, 2022
From
Finch Therapeutics Group, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 24, 2022
Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 27, 2022
Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 02, 2022
Via
Benzinga
Benzinga Before The Bell: Elon Musk's Demand For Broad Twitter Data Dismissed, Xiaomi Wants To Join EV Race, Bed Bath & Beyond Plans To Share Turnaround Strategy Next Week And Other Top Financial Stories Friday, August 26
August 26, 2022
CNBC The Aviation Sector Is Slammed By Sky-High Rents
Via
Benzinga
After Six Years Of Collaboration, Takeda Walks Away From Microbiome Drug Pact
August 26, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
August 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 09, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.
Via
Benzinga
Acurx Pharmaceuticals Is Under The Radar, That’s Excellent News For Investors Wanting Exposure To Billion Dollar CDI Treatment Market ($ACXP)
June 06, 2022
Via
AB Newswire
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
April 29, 2022
Via
Benzinga
Stock Market Recap: This Week’s 5 Top Stories
April 29, 2022
It's time for a stock market recap as we go over the hottest stories that traders need to know about from this last week!
Via
InvestorPlace
70 Biggest Movers From Friday
May 02, 2022
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)...
Via
Benzinga
Is ROKU Stock a Buy After Earnings? 4 Analysts Weigh In on Roku.
April 29, 2022
Roku (ROKU) stock is in the news today with investors wondering if the company's shares are worth buying after its earnings report.
Via
InvestorPlace
48 Stocks Moving In Friday's Mid-Day Session
April 29, 2022
Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS. GTY Technology Holdings Inc. (NASDAQ:...
Via
Benzinga
Why Is Finch Therapeutics (FNCH) Stock Up 30% Today?
April 29, 2022
Finch Therapeutics (FNCH) stock is rising higher on Friday following news that the FDA has released its clinical hold on CP101.
Via
InvestorPlace
Peering Into Finch Therapeutics Group's Recent Short Interest
April 29, 2022
Finch Therapeutics Group's (NASDAQ:FNCH) short percent of float has fallen 8.92% since its last report. The company recently reported that it has 214.50 thousand shares sold short...
Via
Benzinga
Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points
April 29, 2022
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday.
Via
Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
April 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 29, 2022
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.